Related Experiment Video
Updated: May 26, 2026

08:43
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors
Dirk Strumberg1, Beate Schultheis, Ulrich Traugott
1Department of Hematology and Oncology, Marienhospital Herne, University of Bochum, Herne, Germany. dirk.strumberg@marienhospital-herne.de
International Journal of Clinical Pharmacology and Therapeutics
|December 24, 2011
Abstract
No abstract available in PubMed .

